Used in conjunction with the oral sonosensitizing agent 5-ALA, the sonodynamic therapy led to a median OS of 15.7 months in ...

Alpheus Medical, Inc., a private, clinical-stage oncology company pioneering sonodynamic therapy (SDT) for the treatment of ...

State Key Laboratory of Fine Chemicals, Frontiers Science Center for Smart Materials Oriented Chemical Engineering, Dalian University of Technology, Dalian 116024, P. R. China ...

The results from their first-in-human study demonstrated that median overall survival was doubled and progression-free survival improved 3-fold The Company's novel sonodynamic therapy platform ...

Biomaterials Research Center, School of Biomedical Engineering, Southern Medical University, Guangzhou 510515, PR China ...

Food - Allergen - Crustacean and shellfish Distribution: National See the affected products and product photos for this recall SOURCE Canadian Food Inspection Agency (CFIA) ...

Universal Health Services, Inc. announced today that its Board of Directors voted to pay a cash dividend of $0.20 per share on December 17, 2024 to shareholders of record as of December 3, 2024.

Preclinical and clinical studies are showing promising results for emerging therapies like ferroptosis-based therapy, which induces an iron-dependent form of cell death, sonodynamic therapy ...